Through all the market madness of the past two years, there has been one truth universally acknowledged by the analysts who ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

For any one with a straining waistband, the next step was once a given: heading to the local church hall for an evening of ...

Stock markets in North America was a roller coaster on Wednesday and Thursday after U.S. President Donald Trump paused his so ...

But this is just the start. GLP-1 drugs (specifically Novo Nordisk’s Ozempic, Rybelsus and Wegovy and Eli Lilly’s Mounjaro ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

From General Mills to Hormel, the food industry is reckoning with more consumers on GLP-1 meds who are eating healthier and ...

WeightWatchers has plans to file for bankruptcy in the coming months, a source familiar with the matter said on Wednesday.

Habitual, which is run by CEO and co-founder Napala Pratini, has landed £1m from Lexham Partners, a prominent backer of early ...

WeightWatchers faces bankruptcy with £1.25 billion ($1.6 billion) in debt, losing clients to drugs like Ozempic. Can the ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Novo ...